Skip to main content
OpenTrials

Clinical trial condition

Orthomyxoviridae Infections

Explore clinical trials studying Orthomyxoviridae Infections. Study availability and eligibility vary by location and protocol.

1,810 public trials 84 recruiting studies
Refine in advanced search Browse all conditions

Orthomyxoviridae Infections trial results

Completed

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults 60 Years of Age and Older

NCT04498832

Conditions
Healthy Volunteers, Infections, Influenza Immunization, +6 more
Locations
  • Investigational Site Number 3920005 Fukuoka, Japan
  • Investigational Site Number 3920004 Koganeishi, Japan
  • Investigational Site Number 3920006 Kumamoto, Japan
  • Investigational Site Number 3920001 Osaka, Japan
View Trial Details
Completed

Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .

NCT05779020

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • Instituto Auto Imune de Pesquisa e Educação Continuada - Real Hospital Português de Beneficência em Pernambuco (Site REC01) Recife, Pernambuco, Brazil
  • Centro Oncológico de Roraima - CECOR (Site BVB-01) Boa Vista, Roraima, Brazil
  • Centro de Pesquisas Clínicas da Universidade Federal de Sergipe (Site AJU01) Laranjeiras, Sergipe, Brazil
  • Hospital das Clínicas da Faculdade de Medicina Ribeirão Preto - USP (Site RAO 04) Ribeirão Preto, São Paulo, Brazil
View Trial Details
Completed

COVID-19 Vaccine Uptake Amongst Underserved Populations in East London

NCT05866237

Conditions
Behavior, COVID-19, Coronaviridae Infections, +17 more
Locations
  • Church Road Health London, United Kingdom
  • Glen Road Surgery London, United Kingdom
  • St Andrews Health Centre/ St Pauls Way Health Centre London, United Kingdom
  • St Stephen's Health Centre London, United Kingdom
View Trial Details
Completed

Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects

NCT04451954

Conditions
Healthy Volunteers, Infections, Influenza Immunisation, +6 more
Locations
  • Investigational Site Number 8400003 San Diego, California, United States
  • Investigational Site Number 8400002 Melbourne, Florida, United States
  • Investigational Site Number 8400004 Orlando, Florida, United States
  • Investigational Site Number 8400001 Peoria, Illinois, United States
View Trial Details
Completed

Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age

NCT04210349

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • Investigational Site Number 1561000 Kunming, China
  • Investigational Site Number 1561001 Lincang, China
  • Investigational Site Number 1561002 Lincang, China
  • Investigational Site Number 1561003 Lincang, China
View Trial Details
Completed

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

NCT05426174

Conditions
Healthy Volunteers, Infections, Influenza Immunization, +6 more
Locations
  • AES - DRS - Optimal Research_Site 8400007 Huntsville, Alabama, United States
  • Central Phoenix Medical Clinic, LLC_Site: 8400010 Phoenix, Arizona, United States
  • Optimal Research San Diego, LLC_Site: 8400009 San Diego, California, United States
  • AES - DRS - Optimal Research_Site 8400002 Melbourne, Florida, United States
View Trial Details
Completed

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older

NCT04024228

Conditions
Healthy Volunteers, Infections, Influenza Immunization, +6 more
Locations
  • Investigational Site Number 0560001 Ghent, Belgium
  • Investigational Site Number 0560002 Wilrijk, Belgium
  • Investigational Site Number 2500001 Gières, France
  • Investigational Site Number 2500004 Paris, France
View all 17 locations
View Trial Details
Completed

Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Adults With Chronic Disease

NCT06600490

Conditions
Behavior, Behavior and Behavior Mechanisms, Infections, +7 more
Locations
  • Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte Hellerup, Capital Region, Denmark
View Trial Details

Related conditions